Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 27 min 16 sec ago

VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation

Fri, 07/22/2016 - 14:52
MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - VIVUS, Inc. (VVUS) today announced that the United States District Court for the District of New Jersey has issued a claim construction (Markman) ruling governing patent litigation brought by VIVU...
Biopharmaceuticals, Generics, Litigation
VIVUS, Actavis Laboratories, Teva Pharmaceutical, Qsymia, phentermine

ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer

Fri, 07/22/2016 - 14:47
YONKERS, NY--(Healthcare Sales & Marketing Network) - ContraFect Corporation (CFRX) (CFRXW) ("ContraFect," "we," or the "Company"), a biotechnology company focused on the discovery and development of protein and antibody thera...
Biopharmaceuticals, Personnel
ContraFect, antimicrobial-resistant infection

LabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical

Thu, 07/21/2016 - 20:47
BOSTON, July 21, 2016 -- (Healthcare Sales & Marketing Network) -- LabStyle Innovations Corp. (DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today that it has signed an agreement with GEMCO Medical, an established healthcare di...
Devices, Monitoring, Distribution
LabStyle Innovations, Blood Glucose Monitor, GEMCO Medical

Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma(R)

Thu, 07/21/2016 - 20:44
CLEARWATER, Fla.--(Healthcare Sales & Marketing Network)--Bovie Medical (NYSE MKT:BVX), announced a sales channel partnership agreement with Hologic, effective immediately. Hologic will add Bovie’s J-Plasma® product line to its world class portfolio...
Devices, Surgery, Distribution
Bovie Medical, J-Plasma, Hologic

Relievant Medsystems, Inc. Receives FDA 510(k) Clearance for INTRACEPT(R) for the Relief of Chronic Low Back Pain

Thu, 07/21/2016 - 20:37
REDWOOD CITY, Calif., July 21, 2016 -- (Healthcare Sales & Marketing Network) -- Relievant Medsystems, Inc., a privately held medical device company pioneering the therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pai...
Devices, Orthopaedic, Neurosurgery, FDA
Relievant Medsystems, INTRACEPT, Intraosseous Nerve Ablation, Low Back Pain

ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer

Thu, 07/21/2016 - 20:33
TORONTO, July 21, 2016 (Healthcare Sales & Marketing Network) - ProMIS Neurosciences ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announce...
Biopharmaceuticals, Neurology, Personnel
ProMIS Neurosciences, Alzheimer's disease

TomoTherapy(R) System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients

Thu, 07/21/2016 - 14:47
SUNNYVALE, Calif., July 21, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today preliminary results from a prospective, phase II trial evaluating once-daily accelerated partial breast irradiation (APBI) in patient...
Devices, Oncology
Accuray, TomoTherapy, partial breast irradiation, radiotherapy

Vasorum Ltd. Receives FDA Approval for Celt ACD(R) Vascular Closure Device

Thu, 07/21/2016 - 14:39
DUBLIN, July 21, 2016 -- (Healthcare Sales & Marketing Network) --Vasorum Ltd. The developer and manufacturer of the novel Celt ACD® vascular closure device has received approval of its PMA application from the US Food and Drug Administration (FDA). C...
Devices, Interventional, FDA
Vasorum, Celt ACD, vascular closure device

Mylan Launches Generic Crestor(R) Tablets

Wed, 07/20/2016 - 16:36
HERTFORDSHIRE, England and PITTSBURGH, July 20, 2016 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Rosuvastatin Calcium Tablets, 5 mg, 10 mg, 20 mg and 40 mg, which is a generic version of A...
Biopharmaceuticals, Generics, FDA, Product Launch
Mylan, Rosuvastatin, Crestor, AstraZeneca

Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations

Wed, 07/20/2016 - 16:32
MADISON, Wis., July 20, 2016 -- (Healthcare Sales & Marketing Network) -- Cellectar Biosciences, Inc. (CLRB) ("the company"), an oncology-focused biotechnology company, today announces the appointment of Jarrod Longcor as senior vice president of...
Biopharmaceuticals, Oncology, Personnel
Cellectar Biosciences, phospholipid drug conjugate, multiple myeloma

Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA

Wed, 07/20/2016 - 16:29
LEE'S SUMMIT, Mo., July 20, 2016 -- (Healthcare Sales & Marketing Network) -- Viracor-IBT Laboratories, Inc. (Viracor-IBT), a wholly-owned subsidiary of Eurofins Scientific (EUFI.PA), today announced that it received Emergency Use Authorization (EUA) from...
Diagnostics, FDA
Viracor-IBT Laboratories, Zika Virus

Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System

Wed, 07/20/2016 - 16:26
IRVINE, Calif., July 20, 2016 -- (Healthcare Sales & Marketing Network) -- Acclarent, Inc., today announced the U.S. availability of the RELIEVA SCOUT® Multi-Sinus Dilation System, which utilizes Balloon Sinuplasty technology to safely confirm and dil...
Devices, Interventional, Product Launch
Acclarent, RELIEVA SCOUT, Multi-Sinus Dilation System, sinus dilation

Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer

Wed, 07/20/2016 - 14:51
BOSTON, July 20, 2016 -- (Healthcare Sales & Marketing Network) -- Juniper Pharmaceuticals, Inc. (JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced that its Board of Directors has appointed veter...
Biopharmaceuticals, Personnel
Juniper Pharmaceuticals

Vensica Medical Completes $500,000 Finance Round

Tue, 07/19/2016 - 15:21
MISGAV, Israel, July 19, 2016 -- (Healthcare Sales & Marketing Network) -- Vensica Medical, a portfolio company of Trendlines Medical, announced the completion of a financing round of US$500,000 from a private foreign investor. Vensica is developing a ne...
Devices, Drug Delivery, Urology, Venture Capital
Vensica Medical, overactive bladder, Botox

TapImmune Appoints Dr. John N. Bonfiglio as President and Chief Operating Officer

Tue, 07/19/2016 - 15:18
JACKSONVILLE, Florida, July 19, 2016 -- (Healthcare Sales & Marketing Network) -- TapImmune, Inc. (TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the...
Biopharmaceuticals, Oncology, Personnel
TapImmune, immunotherapy

Access Scientific Debuts POWERWAND XL Midline Catheter

Tue, 07/19/2016 - 15:16
SAN DIEGO, July 19, 2016 -- (Healthcare Sales & Marketing Network) -- Access Scientific has introduced the POWERWAND(TM) XL, a companion to the POWERWAND ALL-IN-ONE. The new POWERWAND XL is designed specifically for clinicians who prefer to use a component...
Devices, Product Launch
Access Scientific, POWERWAND, Seldinger Technique

Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer

Tue, 07/19/2016 - 15:12
PLYMOUTH, Minn., July 19, 2016 -- (Healthcare Sales & Marketing Network) -- Monteris Medical today announced that its Board of Directors has appointed Martin J. Emerson as its President and Chief Executive Officer effective immediately. Monteris Medical ...
Devices, Oncology, Neurosurgery, Personnel
Monteris Medical, NeuroBlate

Preceptis Medical Launches the Hummingbird(TM) TTS Ear Tube Delivery System

Tue, 07/19/2016 - 15:07
PLYMOUTH, Minn., July 19, 2016 -- (Healthcare Sales & Marketing Network) -- Preceptis Medical announces its U.S. limited market launch of the Hummingbird TTS (Tympanostomy Tube System) that uses conscious (moderate) sedation for children's ear tube placem...
Devices, Product Launch
Preceptis Medical, Hummingbird, Tympanostomy Tube

Platinum Diagnostic Lab Announces the Availability of Thermo Scientific ImmunoCAP(TM) Allergy Testing Products

Tue, 07/19/2016 - 14:50
LINDEN, N.J., July 18, 2016 -- (Healthcare Sales & Marketing Network) -- Platinum Diagnostic Lab announces the availability of Thermo Scientific ImmunoCAP™ allergy testing products. ImmunoCAP measures the concentration of immunoglobulin E (IgE), which is ...
Diagnostics, Product Launch
Platinum Diagnostic Lab, ImmunoCAP, immunoglobulin E

Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials

Mon, 07/18/2016 - 15:25
CRANFORD, N.J., July 18, 2016 -- (Healthcare Sales & Marketing Network) -- Citius Pharmaceuticals, Inc. ("Citius") (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced to...
Citius Pharmaceuticals, Mino-Lok, CRBSI

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong